Hypoxia-cognition training showed no significant effects on prefrontal or hippocampal microstructure in remitted mood disorder patients.
The ALTIBRAIN trial enrolled 57 participants (mean age 39 years, 70% female) with major depressive disorder or bipolar disorder who were in partial or full remission. Participants received either three weeks of daily normobaric hypoxia (12% oxygen) combined with cognitive training five to six days per week, or treatment-as-usual. The primary outcome assessed Neurite Orientation Dispersion and Density Imaging (NODDI) metrics, specifically neurite density index and orientation dispersion index, in the prefrontal cortex and hippocampus at one month follow-up.
Results indicated no significant effects of the hypoxia-cognition training compared to treatment-as-usual on NODDI metrics in either brain region. All p-FDR values were greater than or equal to 0.832. Furthermore, no significant associations were observed between microstructural changes and changes in executive function or global cognition, with all p-FDR values greater than or equal to 0.721. Baseline associations between microstructure and cognitive function were also not significant (all p > 0.40).
Safety data, including adverse events and tolerability, were not reported in the study. Key limitations include a single follow-up assessment and the fact that NODDI-derived metrics did not capture structural correlates of the cognitive response. Consequently, the study does not support claims that this intervention modifies prefrontal or hippocampal microstructure in individuals with remitted mood disorders.